Megan, what's been your experience with engaging that process of education or enlightenment to a court who, who may have less familiar, familiarity with the regulatory requirements? How do you navigate that dynamic of maybe providing education to the judge who's gonna be making other decisions in, in the case without overstepping, while also ensuring that the right steps are taken to protect this kind of information.

You know, I, I think the challenge is often that everyone's interests aren't necessarily aligned, particularly if you're embroiled in actual litigation.

And so the other side is, they're trying to get as much information as possible, and so they're likely asking for the universe.

And the judge or arbitrator, their motivation is probably just to get you either off the Zoom or out of their courtroom as soon as possible.

Um, so, y- you know, we're, we're, we're navigating that.

I think the way that I try to approach it is to help both our colleagues on the other side and decision-makers in these cases really understand what the implications are to either providing too much information or requiring us to provide information without a sufficient amount of time to navigate even just basic things like redaction of PHI.

And, you know, really trying to get everyone to a place where we've narrowed by scope what really needs to be discoverable in any case.

Megan, what's been your experience with the, the effect that these business structure arrangements in, in the healthcare industry have on both litigation and, and settlement?